iBio (IBIO) vs Xilio Therapeutics (XLO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iBio (IBIO) has outperformed Xilio Therapeutics (XLO) over the past year, gaining 5.7% versus a loss of 21.7%. Xilio Therapeutics is the larger company by market cap ($59.3 million vs $59.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IBIO | XLO |
|---|---|---|
| Share price | $0.92 | $9.01 |
| Market cap | $59.16M | $59.29M |
| 1-day change | -8.91% | 0.00% |
| YTD return | -52.33% | +0.56% |
| 1-year return | +5.75% | -21.71% |
| 5-year return | -99.80% | — |
| EPS (TTM) | $-0.32 | $-0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.82 | $12.59 |
| 52-week low | $0.78 | $6.47 |
| Distance from 52-week high | -75.92% | -28.41% |
| Average volume | 735.37K | 19.05K |
| Shares outstanding | 64.31M | 6.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IBIO has outperformed XLO by 27.5 percentage points over the past year.
IBIO vs XLO FAQ
Which is bigger, iBio or Xilio Therapeutics?
Xilio Therapeutics (XLO) is larger, with a market capitalization of $59.29M compared with $59.16M for iBio (IBIO).
Which stock has performed better over the past year, IBIO or XLO?
IBIO returned +5.75% over the past 12 months, compared with -21.71% for XLO (price return, excluding dividends). Past performance does not predict future results.
Are iBio and Xilio Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.